论文部分内容阅读
目的 从治疗学的角度探讨慢性盆腔疼痛综合征的可能病因及治疗选择。方法将 132例门诊诊断为慢性盆腔疼痛综合征的患者在平均年龄、病程及慢性前列腺炎症状评分无统计学意义的基础上分为 3组 :A组患者口服塞来昔布 ,B组患者口服前列回春胶囊 ,C组患者同时服用上述 2种药物 ,治疗随访 6周 ,比较治疗前后 3组患者慢性前列腺炎症状评分及前列腺液中卵磷脂小体数量的变化。结果 每组患者治疗前后的症状评分和前列腺液中卵磷脂小体数量的变化均有统计学意义 ;C组分别同A组、B组比较 ,治疗后上述各项指标均有统计学意义。结论 炎症反应能导致慢性盆腔疼痛综合征 ;特异性环氧化酶Ⅱ抑制剂及前列回春胶囊对慢性盆腔疼痛综合征均有一定疗效 ;中西医结合治疗优于单一治疗
Objective To explore the possible causes and treatment options of chronic pelvic pain syndrome from the perspective of therapeutics. Methods One hundred and thirty-two outpatients diagnosed as chronic pelvic pain syndrome were divided into three groups based on the average age, course of disease and symptom scores of chronic prostatitis: group A received oral celecoxib and group B received oral Qianlie Huichun Capsule, C group patients taking the above two drugs at the same time, the treatment was followed up for 6 weeks, the chronic prostatitis symptom scores and the amount of lecithin in prostatic fluid were compared before and after treatment. Results The scores of symptoms before and after treatment in each group and the numbers of lecithin in prostatic fluid had statistical significance. The above indexes in each group were statistically significant compared with those in group A and group B respectively. Conclusion Inflammatory reaction can lead to chronic pelvic pain syndrome. Specific cyclooxygenase Ⅱ inhibitor and Qianlie Huichun capsule have some curative effect on chronic pelvic pain syndrome. Integrative treatment is better than single treatment